Stock Earnings

Question 1

What are Enanta Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Enanta Pharmaceuticals Inc has a total asset of $280, Net loss of $-81

Question 2

What are the key financial ratios for ENTA?

Accepted Answer

Enanta Pharmaceuticals Inc's Current ratio is 1.29, has a Net margin is -124.61, sales per share of $3.04.

Question 3

How is Enanta Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Enanta Pharmaceuticals Inc largest revenue segment is Small Molecule Drugs, at a revenue of 67,635,000 in the most earnings release.For geography, United States is the primary market for Enanta Pharmaceuticals Inc, at a revenue of 67,635,000.

Question 4

Is Enanta Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Enanta Pharmaceuticals Inc has a net loss of $-81

Question 5

Does Enanta Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Enanta Pharmaceuticals Inc has liability of 216

Question 6

How many outstanding shares for Enanta Pharmaceuticals Inc?

Accepted Answer

Enanta Pharmaceuticals Inc has a total outstanding shares of 21.38

Breakdown	TTM	09/30/2025	09/30/2024	09/30/2023	09/30/2022	09/30/2021
Revenue	65	65	67	79	86	97
Revenue Growth (YoY)	-3%	-3%	-15%	-8%	-11%	-20%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	43	43	57	52	45	32
Research & Development	106	106	131	163	164	174
Operating Expenses	150	150	189	216	210	206
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-83	-83	-117	-131	-122	-107
Income Tax Expense	-1	-1	-1	2	0	-28
Net Income	-81	-81	-116	-133	-121	-79
Net Income Growth	-30%	-30%	-13%	10%	53%	119%
Shares Outstanding (Diluted)	21.37	21.33	21.15	21	20.6	20.2
Shares Change (YoY)	1%	1%	1%	2%	2%	2%
EPS (Diluted)	-3.83	-3.83	-5.48	-6.38	-5.91	-3.92
EPS Growth	-30%	-30%	-14%	8%	51%	117%
Free Cash Flow	-32	-32	-96	-112	-86	-70
Free Cash Flow Per Share	-1.49	-1.49	-4.53	-5.33	-4.17	-3.46
Gross Margin	--	--	--	--	--	--
Operating Margin	-130.76%	-130.76%	-180.59%	-173.41%	-143.02%	-112.37%
Profit Margin	-124.61%	-124.61%	-173.13%	-168.35%	-140.69%	-81.44%
Free Cash Flow Margin	-49.23%	-49.23%	-143.28%	-141.77%	-100%	-72.16%
EBITDA	-81	-81	-119	-135	-121	-106
EBITDA Margin	-124.61%	-124.61%	-177.61%	-170.88%	-140.69%	-109.27%
D&A For EBITDA	4	4	2	2	2	3
EBIT	-85	-85	-121	-137	-123	-109
EBIT Margin	-130.76%	-130.76%	-180.59%	-173.41%	-143.02%	-112.37%
Effective Tax Rate	1.2%	1.2%	0.85%	-1.52%	0%	26.16%

Enanta Pharmaceuticals Inc (ENTA) Price

ENTA Stock Price Chart

ENTA Income

Follow-Up Questions